Trial Profile
Acute Lung Injury Clinical Trials Incubator Unit
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Atibuclimab (Primary)
- Indications Acute lung injury
- Focus Therapeutic Use
- 28 May 2017 New trial record